Jiandong Xu
CIK 1920399 · Chief Financial Officer · last filed 2026-04-29
Jiandong Xu is a Chief Financial Officer who has filed 5 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing shows the insider bought $2.6K of ESLAW on Apr 29, 2026. Across all open-market trades the lifetime net is +$5.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $36.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$36.7K
3
5
$5.10M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESLAW | Chief Financial Officer | 282,188 | $0.13 | $36.7K | $2.6K | 2 | 2026-04-29 |
| Semnur Pharmaceuticals, Inc. (DECAW) Delisted | 10%+ Owner | — | $0.04 | — | $0 | 1 | 2024-09-16 |
| Semnur Pharmaceuticals, Inc. (DECAU) Delisted | 10%+ Owner | 510,000 | $11.84 | $6.04M | $5.10M | 2 | 2022-05-24 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-29 | ESLAW | Buy (P) | +2,100 | $2.6K | EDGAR |
| 2025-02-14 | ESLAW | Grant (A) | — | $0 | EDGAR |
| 2024-09-16 | Semnur Pharmaceuticals, Inc. (DECAW) Delisted | Sell (S) | — | $0 | EDGAR |
| 2022-05-24 | Semnur Pharmaceuticals, Inc. (DECAU) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-04-13 | Semnur Pharmaceuticals, Inc. (DECAU) Delisted | Buy (P) | +510,000 | $5.10M | EDGAR |